Leaf extract of Centella asiatica has been used as an alternative medicine for memory improvement in the Indian Ayurvedic system of medicine for a long time. Although several studies have revealed its effect in ameliorating the cognitive impairment in rat models of Alzheimer's disease, the molecular mechanism of C. asiatica on neuroprotection still remains unexplained. In this study, we investigated the effects of C. asiatica water extract on activity of subtypes of phospholipase A2 (PLA2) in primary cultures of rat cortical neurons and quantified by HPLC a possible molecule responsible for the activity. The cPLA2 and sPLA2 activities were inhibited in vitro by asiaticoside present in the water extract of C. asiatica. This extract may be a candidate for the treatment of neurodegenerative processes because of its pharmacological activity in the brain and its low toxicity, as attested by its long popular use as a natural product.
SchaefferE.L., GattazW.F. (2008) Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Psychopharmacology, 198, 1–27.
2.
(a) StranahanA.M., MattsonM.P. (2012) Recruiting adaptive cellular stress responses for successful brain ageing. Nature Review Neuroscience.13, 209–216;(b) Sun GY, Xu J, Jensen MD, Simonyi A. (2004) Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. Journal of Lipid Research, 45, 205–213.
SanfeliuC., HuntA., PatelA. (1990) Exposure to N-methyl-D-aspartate increases release of arachidonic acid in primary cultures of rat hippocampal neurons and not in astrocytes. Brain Research, 526, 241–248.
5.
NirmalN., PrabaG., VelmuruganD. (2008) Modeling studies on phospholipase A2-inhibitor complexes. Indian Journal of Biochemistry & Biophysics, 45, 256–262.
6.
BarbosaN.R., PittellaF., GattazW.F. (2008) Centella asiatica water extract inhibits iPLA2 and cPLA2 activities in rat cerebellum. Phytomedicine, 15, 896–900.
7.
(a) MiyakeA., YamamotoH., TakebayashiY., ImaiH., HondaK. (1992) The novel natural product YM-26567-1 [(+)-trans-4-(3-dodecanoyl-2,4,6-trihydroxyphenyl)-7-hydroxy-2-(4-hydroxyphenyl)chroman]: a competitive inhibitor of group II phospholipase A2. Journal of Pharmacology and Experimental Therapeutics, 263, 1302–1307;(b) De Marino S, Iorizzi M, Zollo F, Debitus C, Menou JL, Ospina LF, Alcaraz MJ, Payá M. (2000) New pyridinium alkaloids from a marine sponge of the genus Spongia with a human phospholipase A(2) inhibitor profile. Journal of Natural Products, 63, 322–326.
8.
(a) Veerendra KumarM.H., GuptaY.K. (2003) Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clinical and Experimental Pharmacology and Physiology, 30, 336–342;(b) Lee MK, Kim SR, Sung SH, Lim D, Kim H, Choi H, Park HK, Je S, Ki YC. (2000) Asiatic acid derivatives protect cultures cortical neurons from glutamate-induced excitotoxicity. Research Communications in Molecular Pathology and Pharmacology, 108, 75–86.
BonfillM., MangasS., CusidóR.M., OsunaL., PiñolM.T., PalazónJ. (2006) Identification of triterpenoid compounds of Centella asiatica by thin-layer chromatography and mass spectrometry. Biomedical Chromatography, 20, 151–153.
11.
ParkB.C., PaekS.H., LeeY.S., KimS.J., LeeE.S., ChoiH.G., YongC.S., KimJ.A. (2007) Inhibitory effects of asiatic acid on 7,12-dimethylbenz[a]anthrax-cene and 12-O-tetradecanoylphorbol 13-acetate-induced tumor promotion in mice. Biological & Pharmaceutical Bulletin, 30, 176–179.
12.
Malaplate-ArmandC., Florent-BéchardS., YoussefI., KozielV., SponneI., KriemB., Leininger-MullerB., OlivierJ.L., OsterT., PillotT. (2006) Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiology of Disease, 23, 178–189.
13.
MosesG.S., JensenM.D., LueL.F., WalkerD.G., SunA.Y., SimonyiA., SunG.Y. (2006) Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. Journal of Neuroinflammation, 3, 28–38.
14.
Mook-JungI., ShinJ., YunS.H., HuhK., KohJ.Y., ParkH.K., JewS., JungM.W. (1999) Protective effects of asiaticoside derivatives against beta-amyloid neurotoxicity. Journal of Neuroscience Research, 58, 417–425.
15.
(a) GattazW.F., SchmittA., MarasA. (1995) Increased platelet phospholipase A2 activity in schizophrenia. Schizophrenia Research, 16, 1–6. (b) Mendes CT, Gattaz WF, Schaeffer EL, Forlenza OV. (2005) Modulation of phospholipase A2 activity in primary cultures of rat cortical neurons. Journal of Neural Transmission, 112, 1297–1308.
16.
LowryO.H., RowebroughN.J., FarrL.A., RandallR.J. (1951) Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
